DLGAP1

Across TCGA pan-cancer cohorts, DLGAP1 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated DLGAP1 data layer compared with 25 for mass-spec protein and 8 for mutation status.

The strongest signal is observed in glioblastoma multiforme (GBM), where higher DLGAP1 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated DLGAP1 expression acts as an unfavorable survival marker, although some lineages such as GBM show a favorable association.

GBM, UCEC, and LSCC are the cancer types where DLGAP1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
GBM	DFS	Tertile	All	0.810	0.625	.002	18	view →
UCEC	DFS	Median	All	0.927	1.000	.021	4	view →
LSCC	DFS	Median	All	0.430	0.889	.001	4	view →
LUAD	DFS	Median	All	0.368	1.000	.043	1	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

DLGAP1–GBM (DFS)

Open the GBM breakdown →